Search Results - "Banihashemi, Seyed Reza"
-
1
Safety and Efficacy of Combined Intramuscular/Intranasal RAZI-COV PARS Vaccine Candidate Against SARS-CoV-2: A Preclinical Study in Several Animal Models
Published in Frontiers in immunology (26-05-2022)“…Several vaccine candidates for COVID-19 have been developed, and few vaccines received emergency approval with an acceptable level of efficacy and safety. We…”
Get full text
Journal Article -
2
Immunogenicity and safety of RAZI recombinant spike protein vaccine (RCP) as a booster dose after priming with BBIBP-CorV: a parallel two groups, randomized, double blind trial
Published in BMC medicine (20-02-2024)“…The immunity induced by primary vaccination is effective against COVID-19; however, booster vaccines are needed to maintain vaccine-induced immunity and…”
Get full text
Journal Article -
3
Analysis of immunological and biochemical parameters after booster dose vaccination using protein-based and inactivated virus vaccine for safety
Published in Heliyon (01-11-2024)“…Heterologous vaccines enhance the immune response to new variants and allow flexibility in booster administration when the original vaccine is unavailable…”
Get full text
Journal Article -
4
Immunogenicity and Safety of a Combined Intramuscular/Intranasal Recombinant Spike Protein COVID-19 Vaccine (RCP) in Healthy Adults Aged 18 to 55 Years Old: A Randomized, Double-Blind, Placebo-Controlled, Phase I Trial
Published in Vaccines (Basel) (01-02-2023)“…: This study aimed to determine the safety and immunogenicity of a combined intramuscular/intranasal recombinant spike protein COVID-19 vaccine (RCP). : We…”
Get full text
Journal Article -
5
Safety and efficacy of RCP recombinant spike protein covid-19 vaccine compared to Sinopharm BBIBP: A phase III, non-inferiority trial
Published in Heliyon (15-03-2024)“…We conducted a phase III, non-inferiority trial comparing safety and efficacy of RCP recombinant spike protein Covid-19 vaccine to BBIBP (Sinopharm). Adult…”
Get full text
Journal Article -
6
Extraction of Outer membrane Vesicles from Vaccinal Strain of Bordetella Pertussis as the First Step of a Vaccine Candidate Study Against Pertussis Infection
Published in Majallah-i mīkrub/shināsī-i pizishkī-i Īrān (01-05-2020)“…Background: Pertussis is still one of the major public health problems. The increase of the disease emerged in recent decades due to the replacement of the…”
Get full text
Journal Article -
7
Immunogenicity and safety of RAZI recombinant spike protein vaccine
Published in BMC medicine (20-02-2024)“…Background The immunity induced by primary vaccination is effective against COVID-19; however, booster vaccines are needed to maintain vaccine-induced immunity…”
Get full text
Journal Article -
8
Evaluation of cellular and humoral immune response in chickens immunized with flagellin-adjuvanted inactivated newcastle disease virus
Published in Comparative immunology, microbiology and infectious diseases (01-06-2022)“…The aim of the present study was to evaluate the potential effect of flagellin as adjuvant in Newcastle disease virus (NDV) vaccine on the cellular and humoral…”
Get full text
Journal Article -
9
Evaluation of Outer Membrane Vesicles Obtained from Predominant Local Isolate of Bordetella pertussis as a Vaccine Candidate
Published in Iranian biomedical journal (01-10-2021)“…Background: Pertussis is a current contagious bacterial disease caused by Bordetella pertussis (Bp). Given the prevalence of pertussis, development of new…”
Get full text
Journal Article -
10
Evaluation of Outer Membrane Vesicles Obtained from Predominant Local Isolate of Boredetella pertussis as a Vaccine Candidate
Published in Iranian biomedical journal (01-11-2021)“…Pertussis is a current contagious bacterial disease caused by Bordetella pertussis (Bp). Given the prevalence of pertussis, development of new vaccines is…”
Get full text
Journal Article -
11
Safety and Immunogenicity of Intranasal Razi Cov Pars as a COVID-19 Booster Vaccine in Adults: Promising Results from a Groundbreaking Clinical Trial
Published in Vaccines (Basel) (05-11-2024)“…Protective antibodies in the upper respiratory tract prevent the spread of COVID-19 in the community. Intranasal vaccines could raise the specific secretory…”
Get full text
Journal Article -
12
Development of specific nanobodies (VHH) for CD19 immuno-targeting of human B-lymphocytes
Published in Iranian journal of basic medical sciences (01-05-2018)“…CD19 is a transmembrane glycoprotein of immunoglobulin superfamily. In order to treat lymphoma, monoclonal antibodies (mAb) can target different antigens,…”
Get full text
Journal Article